AI assistant
Sending…
Vir Biotechnology, Inc. — Director's Dealing 2021
Apr 1, 2021
32538_dirs_2021-03-31_bae5bdfd-f467-4922-8f71-84fb76026f0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2021-03-29
Reporting Person: HANLY ANN M. (Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-29 | Common Stock | A | 30000 | $0.00 | Acquired | 30000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-29 | Employee Stock Option (Right to Buy) | $48.38 | A | 60000 | Acquired | 2031-03-28 | Common Stock (60000) | Direct |
Footnotes
F1: 1/4 of the shares subject to the stock option vest and become exercisable on March 29, 2022, and the remainder vest in 36 equal monthly installments thereafter.
More from Vir Biotechnology, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 10
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Mar 23
Board/Management Information
2026
Mar 4
Director's Dealing
2026
Mar 3
Capital/Financing Update
2026
Mar 2
Capital/Financing Update
2026
Feb 26